Published in Infect Immun on April 01, 1995
Type III protein secretion systems in bacterial pathogens of animals and plants. Microbiol Mol Biol Rev (1998) 17.27
Yersinia pestis--etiologic agent of plague. Clin Microbiol Rev (1997) 14.63
Common themes in microbial pathogenicity revisited. Microbiol Mol Biol Rev (1997) 10.52
Molecular microbial diversity in soils from eastern Amazonia: evidence for unusual microorganisms and microbial population shifts associated with deforestation. Appl Environ Microbiol (1997) 10.52
The virulence plasmid of Yersinia, an antihost genome. Microbiol Mol Biol Rev (1998) 5.78
Yersinia enterocolitica: the charisma continues. Clin Microbiol Rev (1997) 4.70
Suppression of cytokines in mice by protein A-V antigen fusion peptide and restoration of synthesis by active immunization. Infect Immun (1995) 2.43
Bacterial perturbation of cytokine networks. Infect Immun (1998) 1.96
Role of YopP in suppression of tumor necrosis factor alpha release by macrophages during Yersinia infection. Infect Immun (1998) 1.89
Salmonella flagellin induces tumor necrosis factor alpha in a human promonocytic cell line. Infect Immun (1998) 1.72
Phospholipase A of Yersinia enterocolitica contributes to pathogenesis in a mouse model. Infect Immun (1998) 1.67
YopJ of Yersinia spp. is sufficient to cause downregulation of multiple mitogen-activated protein kinases in eukaryotic cells. Infect Immun (1999) 1.49
Differential secretion of interleukin-8 by human epithelial cell lines upon entry of virulent or nonvirulent Yersinia enterocolitica. Infect Immun (1996) 1.30
Defense mechanisms in Peyer's patches and mesenteric lymph nodes against Yersinia enterocolitica involve integrins and cytokines. Infect Immun (1996) 1.28
Characterization of oral Yersinia enterocolitica infection in three different strains of inbred mice. Infect Immun (2004) 1.22
Major outer membrane protein Omp25 of Brucella suis is involved in inhibition of tumor necrosis factor alpha production during infection of human macrophages. Infect Immun (2001) 1.21
Effect of low- and high-virulence Yersinia enterocolitica strains on the inflammatory response of human umbilical vein endothelial cells. Infect Immun (2002) 1.13
Salmonellae activate tumor necrosis factor alpha production in a human promonocytic cell line via a released polypeptide. Infect Immun (1997) 1.09
Binding of SycH chaperone to YscM1 and YscM2 activates effector yop expression in Yersinia enterocolitica. J Bacteriol (2004) 1.03
Suppression of NF-kappaB-mediated beta-defensin gene expression in the mammalian airway by the Bordetella type III secretion system. Cell Microbiol (2005) 1.00
Haemophilus ducreyi infection causes basal keratinocyte cytotoxicity and elicits a unique cytokine induction pattern in an In vitro human skin model. Infect Immun (1998) 0.96
Modulation of cytokine release in ex vivo-stimulated blood from borreliosis patients. Infect Immun (2001) 0.95
alpha(v)beta(3) integrin and bacterial lipopolysaccharide are involved in Coxiella burnetii-stimulated production of tumor necrosis factor by human monocytes. Infect Immun (2000) 0.91
Characterization of the interaction between Yersinia enterocolitica biotype 1A and phagocytes and epithelial cells in vitro. Infect Immun (1999) 0.91
Yersinia enterocolitica-induced interleukin-8 secretion by human intestinal epithelial cells depends on cell differentiation. Infect Immun (1998) 0.91
Contribution of YopB to virulence of Yersinia enterocolitica. Infect Immun (1996) 0.91
Use of defined mutants to assess the role of the Campylobacter rectus S-layer in bacterium-epithelial cell interactions. Infect Immun (2000) 0.89
Enhanced inhibitory effect of ultra-fine granules of red ginseng on LPS-induced cytokine expression in the monocyte-derived macrophage THP-1 cells. Int J Mol Sci (2008) 0.86
Virulence genes and cytokine profile in systemic murine Campylobacter coli infection. Virulence (2015) 0.83
In vivo-induced InvA-like autotransporters Ifp and InvC of Yersinia pseudotuberculosis promote interactions with intestinal epithelial cells and contribute to virulence. Infect Immun (2011) 0.83
Transforming growth factor beta and CD25 are important for controlling systemic dissemination following Yersinia enterocolitica infection of the gut. Infect Immun (2010) 0.79
Mitogen-activated protein kinase-dependent interleukin-1α intracrine signaling is modulated by YopP during Yersinia enterocolitica infection. Infect Immun (2011) 0.79
Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature (1970) 1528.65
High resolution two-dimensional electrophoresis of proteins. J Biol Chem (1975) 133.45
Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods (1983) 114.35
Ribonucleic acid isolated by cesium chloride centrifugation. Biochemistry (1974) 19.75
Identification of a common nucleotide sequence in the 3'-untranslated region of mRNA molecules specifying inflammatory mediators. Proc Natl Acad Sci U S A (1986) 15.20
The inducing role of tumor necrosis factor in the development of bactericidal granulomas during BCG infection. Cell (1989) 10.98
Control of cachectin (tumor necrosis factor) synthesis: mechanisms of endotoxin resistance. Science (1986) 9.19
A highly sensitive cell line, WEHI 164 clone 13, for measuring cytotoxic factor/tumor necrosis factor from human monocytes. J Immunol Methods (1986) 8.88
Yersinia enterocolitica, a primary model for bacterial invasiveness. Rev Infect Dis (1987) 5.48
Intracellular targeting of the Yersinia YopE cytotoxin in mammalian cells induces actin microfilament disruption. Infect Immun (1991) 4.46
Prostaglandin E2 regulates macrophage-derived tumor necrosis factor gene expression. J Biol Chem (1988) 4.44
Regulation of gamma interferon production by natural killer cells in scid mice: roles of tumor necrosis factor and bacterial stimuli. Infect Immun (1991) 4.18
Yersinia antigens in synovial-fluid cells from patients with reactive arthritis. N Engl J Med (1989) 3.68
Macrophages as a source of tumoricidal activity (tumor-necrotizing factor). Infect Immun (1980) 3.41
Experimental Yersinia enterocolitica infection in mice: kinetics of growth. Infect Immun (1974) 3.34
Association between virulence of Yersinia pestis and suppression of gamma interferon and tumor necrosis factor alpha. Infect Immun (1993) 3.16
Dexamethasone and pentoxifylline inhibit endotoxin-induced cachectin/tumor necrosis factor synthesis at separate points in the signaling pathway. J Exp Med (1990) 2.79
Methods for increasing the resolution of two-dimensional protein electrophoresis. Anal Biochem (1988) 2.78
YopB and YopD constitute a novel class of Yersinia Yop proteins. Infect Immun (1993) 2.63
Virus proteins that counteract host immune defenses. Cell (1992) 2.51
Molecular cloning and expression of calcium-regulated, plasmid-coded proteins of Y. pseudotuberculosis. Microb Pathog (1987) 2.45
Regulation and polarized transfer of the Yersinia outer proteins (Yops) involved in antiphagocytosis. Trends Microbiol (1994) 2.14
Endogenous tumor necrosis factor, interleukin-6, and gamma interferon levels during Listeria monocytogenes infection in mice. Infect Immun (1992) 2.07
The Yersinia tyrosine phosphatase: specificity of a bacterial virulence determinant for phosphoproteins in the J774A.1 macrophage. J Exp Med (1992) 2.05
Lymphotoxin. Annu Rev Immunol (1988) 1.94
Molecular mechanisms in down-regulation of tumor necrosis factor expression. Proc Natl Acad Sci U S A (1990) 1.83
A growth-factor dependent B-cell hybridoma. Curr Top Microbiol Immunol (1986) 1.79
Type I IL-1 receptor blockade exacerbates murine listeriosis. J Immunol (1992) 1.78
In vivo neutralization of tumor necrosis factor-alpha and interferon-gamma abrogates resistance to Yersinia enterocolitica infection in mice. Med Microbiol Immunol (1992) 1.73
Virus strategies for evasion of the host response to infection. Trends Microbiol (1994) 1.62
Experimental Yersinia enterocolitica infection in rodents: a model for human yersiniosis. APMIS (1993) 1.60
Activation of collagen type II expression in osteoarthritic and rheumatoid cartilage. Virchows Arch B Cell Pathol Incl Mol Pathol (1992) 1.23
Transition from interleukin 1 beta (IL-1 beta) to IL-1 alpha production during maturation of inflammatory macrophages in vivo. J Exp Med (1992) 1.01
Transcriptional and translational regulation of IL-1 alpha and IL-1 beta account for the control of IL-1 in experimental yersiniosis. Cytokine (1994) 0.84
Evaluation of TNF as antiviral, antibacterial and antiparasitic agent. Biotherapy (1991) 0.80
The cytotoxic protein YopE of Yersinia obstructs the primary host defence. Mol Microbiol (1990) 5.09
Intracellular targeting of the Yersinia YopE cytotoxin in mammalian cells induces actin microfilament disruption. Infect Immun (1991) 4.46
Cyclosporin A mediates immunosuppression of primary cytotoxic T cell responses by impairing the release of interleukin 1 and interleukin 2. Eur J Immunol (1981) 4.31
A secreted protein kinase of Yersinia pseudotuberculosis is an indispensable virulence determinant. Nature (1993) 3.40
Cyclophosphamide-sensitive T lymphocytes suppress the in vivo generation of antigen-specific cytotoxic T lymphocytes. J Exp Med (1977) 3.38
Analysis of the V antigen lcrGVH-yopBD operon of Yersinia pseudotuberculosis: evidence for a regulatory role of LcrH and LcrV. J Bacteriol (1991) 3.32
Reactive oxygen and reactive nitrogen intermediates in innate and specific immunity. Curr Opin Immunol (2000) 3.14
Virus and trinitrophenol hapten-specific T-cell-mediated cytotoxicity against H-2 incompatible target cells. J Exp Med (1976) 3.00
The role of nitric oxide in innate immunity. Immunol Rev (2000) 2.78
Tissue expression of inducible nitric oxide synthase is closely associated with resistance to Leishmania major. J Exp Med (1994) 2.46
Reactivation of latent leishmaniasis by inhibition of inducible nitric oxide synthase. J Exp Med (1996) 2.45
Intracellular targeting of exoenzyme S of Pseudomonas aeruginosa via type III-dependent translocation induces phagocytosis resistance, cytotoxicity and disruption of actin microfilaments. Mol Microbiol (1997) 2.40
T-cell-derived helper factor allows in vivo induction of cytotoxic T cells in nu/nu mice. Nature (1980) 2.39
The V-antigen of Yersinia is surface exposed before target cell contact and involved in virulence protein translocation. Mol Microbiol (1999) 2.37
Functional conservation of the secretion and translocation machinery for virulence proteins of yersiniae, salmonellae and shigellae. EMBO J (1995) 2.30
Type 1 interferon (IFNalpha/beta) and type 2 nitric oxide synthase regulate the innate immune response to a protozoan parasite. Immunity (1998) 2.22
The TEA/ATTS transcription factor CaTec1p regulates hyphal development and virulence in Candida albicans. Mol Microbiol (2000) 2.12
A novel protein, LcrQ, involved in the low-calcium response of Yersinia pseudotuberculosis shows extensive homology to YopH. J Bacteriol (1992) 2.11
Induction of cytotoxic T lymphocytes against I-region-coded determinants: in vitro evidence for a third histocompatibility locus in the mouse. J Exp Med (1975) 2.09
Quantitative detection of Borrelia burgdorferi by real-time PCR. J Clin Microbiol (1999) 1.93
Identification and mapping of the temperature-inducible, plasmid-encoded proteins of Yersinia spp. Infect Immun (1988) 1.90
Langerhans cells transport Leishmania major from the infected skin to the draining lymph node for presentation to antigen-specific T cells. Eur J Immunol (1993) 1.88
The role of T cells in anti-herpes simplex virus immunity. I. Induction of antigen-specific cytotoxic T lymphocytes. J Immunol (1977) 1.86
Differential regulation of IL-9-expression after infection with Leishmania major in susceptible and resistant mice. Immunobiology (1993) 1.85
T-T cell interactions during cytotoxic T lymphocyte (CTL) responses: T cell derived helper factor (Interleukin 2) as a probe to analyze CTL responsiveness and thymic maturation of CTL progenitors. Immunol Rev (1980) 1.78
YopK of Yersinia pseudotuberculosis controls translocation of Yop effectors across the eukaryotic cell membrane. Mol Microbiol (1997) 1.74
Tumor necrosis factor-alpha in combination with interferon-gamma, but not with interleukin 4 activates murine macrophages for elimination of Leishmania major amastigotes. Eur J Immunol (1990) 1.74
T-cell-mediated immune responses induced in vitro: a probe for allograft and tumor immunity. Transplant Rev (1973) 1.74
Antrum- and corpus mucosa-infiltrating CD4(+) lymphocytes in Helicobacter pylori gastritis display a Th1 phenotype. Infect Immun (1998) 1.67
A Th1/Th2-associated chemokine imbalance during infancy in children developing eczema, wheeze and sensitization. Clin Exp Allergy (2011) 1.66
The chaperone-like protein YerA of Yersinia pseudotuberculosis stabilizes YopE in the cytoplasm but is dispensible for targeting to the secretion loci. Mol Microbiol (1995) 1.64
Migration inhibitory factor induces killing of Leishmania major by macrophages: dependence on reactive nitrogen intermediates and endogenous TNF-alpha. J Immunol (1998) 1.63
Visceral leishmaniasis in a German child who had never entered a known endemic area: case report and review of the literature. Clin Infect Dis (2000) 1.63
T-cell-mediated cytotoxicity against herpes simplex virus-infected target cells. Nature (1977) 1.61
The production of IFN-gamma by IL-12/IL-18-activated macrophages requires STAT4 signaling and is inhibited by IL-4. J Immunol (2001) 1.61
Lyt-23+ cyclophosphamide-sensitive T cells regulate the activity of an interleukin 2 inhibitor in vivo. J Exp Med (1981) 1.59
Deficiency in the transcription factor interferon regulatory factor (IRF)-2 leads to severely compromised development of natural killer and T helper type 1 cells. J Exp Med (2000) 1.57
T cell proliferation in the mixed lymphocyte culture does not necessarily result in the generation of cytotoxic T effector cells. Eur J Immunol (1975) 1.56
Early parasite containment is decisive for resistance to Leishmania major infection. Eur J Immunol (1995) 1.55
Dendritic cells in Leishmania major-immune mice harbor persistent parasites and mediate an antigen-specific T cell immune response. Eur J Immunol (1995) 1.54
Fibroblasts as host cells in latent leishmaniosis. J Exp Med (2000) 1.54
Adaptation of cancer cells from different entities to the MDM2 inhibitor nutlin-3 results in the emergence of p53-mutated multi-drug-resistant cancer cells. Cell Death Dis (2011) 1.51
The immune response to Leishmania: mechanisms of parasite control and evasion. Int J Parasitol (1998) 1.51
Interleukin 2 induction in Lyt 1+ 23- T cells from Listeria monocytogenes-immune mice. Infect Immun (1982) 1.49
Injuries and overuse syndromes in powerlifting. Int J Sports Med (2011) 1.48
Parasitism of epidermal Langerhans cells in experimental cutaneous leishmaniasis with Leishmania major. J Infect Dis (1993) 1.47
Functional conservation of the effector protein translocators PopB/YopB and PopD/YopD of Pseudomonas aeruginosa and Yersinia pseudotuberculosis. Mol Microbiol (1998) 1.47
Requirement for type 2 NO synthase for IL-12 signaling in innate immunity. Science (1999) 1.46
Derepressed hyphal growth and reduced virulence in a VH1 family-related protein phosphatase mutant of the human pathogen Candida albicans. Mol Biol Cell (1997) 1.45
Suppressive effect of cyclosporin A on the development of Leishmania tropica-induced lesions in genetically susceptible BALB/c mice. J Immunol (1986) 1.43
IL-10 converts human dendritic cells into macrophage-like cells with increased antibacterial activity against virulent Mycobacterium tuberculosis. J Immunol (2000) 1.42
Invasion, control and persistence of Leishmania parasites. Curr Opin Immunol (1996) 1.42
Rapidly fatal leishmaniasis in resistant C57BL/6 mice lacking TNF. J Immunol (2001) 1.42
Neutralization of endogenous IL-6 suppresses induction of IL-1 receptor antagonist. J Immunol (1995) 1.40
IL-1 beta is secreted by activated murine macrophages as biologically inactive precursor. J Immunol (1990) 1.38
Virulence plasmid-encoded YopK is essential for Yersinia pseudotuberculosis to cause systemic infection in mice. Infect Immun (1995) 1.36
How do protozoan parasites survive inside macrophages? Parasitol Today (1999) 1.35
Natural killer cells participate in the early defense against Leishmania major infection in mice. Eur J Immunol (1993) 1.34
Prevalence of Borrelia burgdorferi and granulocytic and monocytic ehrlichiae in Ixodes ricinus ticks from southern Germany. J Clin Microbiol (1999) 1.33
Construction of a reporter plasmid for screening in vivo promoter activity in Francisella tularensis. FEMS Microbiol Lett (2001) 1.32
Impact of thymus on the generation of immunocompetence and diversity of antigen-specific MHC-restricted cytotoxic T-lymphocyte precursors. Immunol Rev (1981) 1.31
Resistance to murine cutaneous leishmaniasis is mediated by TH1 cells, but disease-promoting CD4+ cells are different from TH2 cells. Eur J Immunol (1990) 1.29
In vitro induction of tumor specific immunity: requirements for T lymphocytes and tumor growth inhibition in vivo. Eur J Immunol (1973) 1.29
Murine toxin of Yersinia pestis shows phospholipase D activity but is not required for virulence in mice. Int J Med Microbiol (2000) 1.28
Intrathymic differentiation of cytotoxic T lymphocyte (CTL) precursors. I. The CTL immunocompetence of peanut agglutinin-positive (cortical) and negative (medullary) Lyt 123 thymocytes. J Immunol (1980) 1.23
The Xid defect determines an improved clinical course of murine leishmaniasis in susceptible mice. Int Immunol (1994) 1.23
[Measurement of complement with a microliter method]. Z Med Mikrobiol Immunol (1969) 1.22
The relationship between body mass and oxygen uptake during running in humans. Med Sci Sports Exerc (1991) 1.22
Dissection of the proliferative and differentiative signals controlling murine cytotoxic T lymphocyte responses. J Exp Med (1982) 1.20
Cytokine interactions in experimental cutaneous leishmaniasis. Interleukin 4 synergizes with interferon-gamma to activate murine macrophages for killing of Leishmania major amastigotes. Eur J Immunol (1991) 1.17
Cytokines in leishmaniasis: a complex network of stimulatory and inhibitory interactions. Immunobiology (1993) 1.17
Temporary presence of self-reactive cytotoxic T lymphocytes during murine lymphocytic choriomeningitis. Nature (1975) 1.17
Kinetics of cell-mediated immunity developing during the course of Leishmania major infection in 'healer' and 'non-healer' mice: progressive impairment of response to and generation of interleukin-2. Immunology (1987) 1.15
Specificity of in vivo tumor rejection assessed by mixing immune spleen cells with target and unrelated tumor cells. Proc Soc Exp Biol Med (1973) 1.14
Coexistence of antigen-specific TH1 and TH2 cells in genetically susceptible BALB/c mice infected with Leishmania major. Immunobiology (1989) 1.14
H-2 restriction as a consequence of intentional priming: T cells of fully allogeneic chimeric mice as well as of normal mice respond to foreign antigens in the context of H-2 determinants not encountered on thymic epithelial cells. Proc Natl Acad Sci U S A (1980) 1.13
Interleukin-10 inhibits antimicrobial activity against Leishmania major in murine macrophages. Scand J Immunol (1994) 1.13
Interactions of human T cell subsets during the induction of cytotoxic T lymphocytes: the role of interleukins. Clin Exp Immunol (1982) 1.13
Regulation of type 2 nitric oxide synthase by type 1 interferons in macrophages infected with Leishmania major. Eur J Immunol (2000) 1.10
Apically exposed, tight junction-associated beta1-integrins allow binding and YopE-mediated perturbation of epithelial barriers by wild-type Yersinia bacteria. Infect Immun (2000) 1.09
Secondary cytotoxic allograft responses in vitro. III. The immunogenicity of allogeneic membrane fragments. Transplantation (1976) 1.08
Mechanism of suppression of macrophage nitric oxide release by IL-13: influence of the macrophage population. J Immunol (1997) 1.08
Anti-theta serum-induced supression of the cellular transfer of tumour-specific immunity to a syngeneic plasma cell tumour. Nat New Biol (1972) 1.08
Apoptosis, p53, bcl-2, and Ki-67 in invasive bladder carcinoma: possible predictors for response to radiochemotherapy and successful bladder preservation. Int J Radiat Oncol Biol Phys (2000) 1.07
Influence of body mass on cross-country ski racing performance. Med Sci Sports Exerc (1992) 1.06
Localization of the Yersinia PTPase to focal complexes is an important virulence mechanism. Mol Microbiol (1999) 1.06
T-T cell interactions during cytotoxic T cell responses. IV. Murine lymphoid dendritic cells are powerful stimulators for helper T lymphocytes. Eur J Immunol (1982) 1.06
Mononuclear cell adhesion and cell adhesion molecule liberation after X-irradiation of activated endothelial cells in vitro. Int J Radiat Biol (2002) 1.05
T cell-mediated cytotoxicity: discrimination between antigen recognition, lethal hit and cytolysis phase. Eur J Immunol (1974) 1.05
Different response of TH1 cells for stimulation with anti-CD3 antibodies. Eur J Immunol (1990) 1.05
Repression of hyphal proteinase expression by the mitogen-activated protein (MAP) kinase phosphatase Cpp1p of Candida albicans is independent of the MAP kinase Cek1p. Infect Immun (2000) 1.04
In vivo sensitization of T cells to hapten-conjugated syngeneic structures of major histocompatibility complex. I. Effect of in vitro culture upon generation of cytotoxic T lymphocytes. Eur J Immunol (1976) 1.04
Effect of T-lymphocyte suppression on the parasite burden in Leishmania major-infected, genetically susceptible BALB/c mice. Infect Immun (1986) 1.04
H-2-linked murine cytotoxic T cell responses specific for sendai virus-infected cells. Eur J Immunol (1978) 1.03
A case of equine granulocytic ehrlichiosis provides molecular evidence for the presence of pathogenic anaplasma phagocytophilum (HGE agent) in Germany. Eur J Clin Microbiol Infect Dis (2003) 1.03
Detection of cutaneous Leishmania infection in paraffin-embedded skin biopsies using the polymerase chain reaction. Trans R Soc Trop Med Hyg (1995) 1.03
Secondary cytotoxic allograft responses in vitro. II. Differentiation of memory T cells into cytotoxic T lymphocytes in the absence of cell proliferation. Eur J Immunol (1976) 1.02